AJANTPHARM

Ajanta Pharma LimitedNSE
₹3,575.3+106.30 (+3.06%)

Market Closed · NSE · INR

Open

₹3,469

High

₹3,598.8

Low

₹3,454

Prev Close

₹3,469

52-Week Range100% from low
₹2,388.4
₹3,575.3

Market Cap

₹43.34 K Cr

Large Cap

P/E (TTM)

41.04

EPS

₹84.53

Div Yield

0.81%

P/B Ratio

9.87

ROE

23.3%

Key Metrics

Forward P/E30.47
Book Value₹362.35
Debt/Equity0.05×
Revenue Growth21.5%
Profit Margin18.76%
Operating Margin25.58%
Volume55.0 K
Avg Volume (20d)1.39 L
Delivery %49.82%
Trades9,228

Analyst Ratings(14 analysts)

Strong Buy

Target Price

₹3,343

-6.5% upside

Strong Buy1
Buy11
Strong Sell2
Low: ₹2,615Median: ₹3,363High: ₹3,950

Current price: ₹3,575

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, incl...

ajantapharma.com9,628 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 28.00/share
23
24
24
25
10 Nov 202528.00
06 Nov 202428.00
08 Feb 202426.00
04 Aug 202310.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.